Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of Emodin 518821

 

CASRN: 518-82-1

Formula: C15-H10-O5

Synonyms/Common Names

  • 1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione
  • 1,3,8-Trihydroxy-6-methylanthraquinone

Short-Term Toxicity

  • 2 weeks (Dosed-Feed)  (C62408)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R&M: 0, 0.06, 0.2, 0.55, 1.2, OR 5% IN FEED.
  • 13 weeks (Dosed-Feed)  (C62408)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R&M: 0, 0.03, 0.06, 0.125, 0.25, OR 0.5% IN FEED.

Long-Term Carcinogenicity

  • 2 years (Dosed-Feed)  (C62408)  Completed 
    • TR-493 (NIH Number: 01-3952)  (Peer Review Approval 05/21/1999A )
      Toxicology and Carcinogenesis Studies of Emodin (CASRN 518-82-1) in F344/N Rats and B6C3F1 Mice (Feed Studies)
    • Rats: F344/N; Mice: B6C3F1
    • Carcinogenesis Results
      • Male Rats No Evidence 
      • Female Rats Equivocal Evidence 
      • Male Mice Equivocal Evidence 
      • Female Mice No Evidence 
    • Dose: R: 0, 280, 830, OR 2500 PPM; 60/SEX M: 0, 160, 312, 625, OR 1250 PPM; 60/SEX.

Special Studies

  • C. elegans  (W518821)  Completed 
    • C. elegans
    • Dose: 100, 75, 50 uM.
  • Toxicokinetic Study (Gavage; Intravenous; Gavage; Intravenous)  (S0322)  Completed 
    • Male and Female Rats: F344/N; Male and Female Mice: B6C3F1
    • Dose: 2 mg/kg bwt [R,M]. 20 & 150 mg/kg bwt [R,M].
  • Toxicokinetic Study (Dosed-Feed; Intravenous; Gavage; Dosed-Feed; Intravenous; Gavage)  (S0575)  Completed 
    • Male and Female Rats: F344/N; Male and Female Mice: B6C3F1
    • Dose: 90D: 0.03, 0.06, 0.125, 0.25 OR 0.5% IN FEED, BLOOD, PAR; 104W: RAT 280, 830 OR 2500 PPM, MICE 160, 312, 625 OR 1250 PPM IN FEED, BLOOD, 90D: FEED, BLOOD, 104W: FEED, BLOOD, .

Genetic Toxicology

  • In Vitro Cytogenetics (CA/SCE)  (A00749)  Completed 
    • Sister Chromatid Exchange Not Tested 
    • Chromosome Aberrations Positive 
  • Micronucleus  (A43429)  Completed 
    • Rats: Fischer 344
    • Male Negative 
  • Micronucleus  (A58400)  Completed 
    • Citation: Witt, K.L., Knapton, A., Wehr, C.M., Hook, G.J., Mirsalis, J., Shelby, M.D., and MacGregor, J.T. Micronucleated Erythrocyte Frequency in Peripheral Blood of B6C3F1 Mice from Short-Term, Prechronic, and Chronic Studies of the NTP Carcinogenesis Bioassay Program. Environ. Molec. Mutagen. Vol. 36 (2000) 163-194
    • Mice: B6C3F1
    • Male Negative 
    • Female Positive 
  • Micronucleus  (A88319)  Completed 
    • Mice: B6C3F1
    • Male Negative 
    • Female Negative 
  • Salmonella  (278686)  Completed 
    •  Weakly Positive 
  • Salmonella  (399853)  Completed 
    •  Positive 

Organ Systems Toxicity

  • 6 to 20 GD Conventional Teratology (Dosed-Feed)  (TER98003)  Completed 
    • Female Rats: Sprague Dawley
    • Dose: 0, 425, 850, OR 1700 PPM.
  • 6 to 17 GD Conventional Teratology (Dosed-Feed)  (TER99003)  Completed 
    • Female Mice: Swiss CD-1
    • Dose: 0, 600, 2500, OR 6000 PPM.
  • 6 to 20 GD Teratology Pilot Studies (Dosed-Feed)  (TRP98003)  Completed 
    • Female Rats: Sprague Dawley
    • Dose: 0, 1700, 3400, 6750, 10, 000 OR 13, 500 PPM.
  • 6 to 17 GD Teratology Pilot Studies (Dosed-Feed)  (TRP99006)  Completed 
    • Female Mice: Swiss CD-1
    • Dose: 0, 750, 1500, 3000, 4500, OR 6000 PPM.